Suicide
Methodology & AI Transparency ⓘ
Suicide Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is suicide? Suicide is the taking of one's own life.
- 2 Real-world patient consensus: Mapped to Anxiety, OCD & Trauma Disorders under ICD-10-CM R45.851 for Suicide clinical workups.
- 3 Typical cash cost range: Workup highlights for Suicide (R45.851): cognitive-behavioral exposure readiness in Suicide (R45.851: evaluation).
- 4 Top reported side effects / signs: Longitudinal Suicide monitoring tracks TSH & Ferritin in Suicide (R45.851: Rule-Out) toward TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (R45.851).
Ask our AI Specialists anything about Suicide
What Is Suicide?
What is suicide? Suicide is the taking of one's own life. It is a death that happens when someone harms themselves because they want to end their life. A suicide attempt is when someone harms themselves to try to end their life, but they do not die. Suicide is a major public health problem and a leading cause of death in the United States. Both suicide and suicide attempts can have lasting harmful effects: People who survive a suicide attempt may have serious injuries that can affect their long-term health. They may also have depression or other mental health concerns. When people die by suicide, it affects their family, friends, and community.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Suicide (R45.851) center on reduced ventromedial prefrontal in Suicide (R45.851: inhibitory tone). Cross-referenced with NIH MeSH (Suicide, Suicidal Ideation), targeted anxiety & ptsd interventions aim to normalize TSH & Ferritin in Suicide (R45.851: Rule-Out).
Common Symptoms & Clinical Signs
- • Having attempted suicide before
- • Depression and other mental health disorders
- • Presentation of Suicide (R45.851): chronic neck, jaw, in Suicide (R45.851: and shoulder muscle)
- • Secondary Suicide clinical sign: avoidance of triggers, in Suicide (R45.851: intrusive trauma memories,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Suicide Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R45.851 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: TSH & Ferritin in Suicide (R45.851: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (R45.851) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Suicide (R45.851: Score) | < 4 (minimal anxiety) (R45.851) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Heart Rate in Suicide (R45.851: Variability (HRV)) | Stable upward personal trend (R45.851) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Suicide
Treatment selection for Suicide depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Suicide)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini: What a 2,213,600-Participant Study Found PATIENT SUMMARY: We reviewed study data for more than two million patients taking drugs called 5α-reductase inhibitors (5-ARIs), which are widely prescribed for urinary problems caused by benign prostate enlargement and for... European urology focus • 2024-09-15 • Meta-Analysis | N = 2,213,600 | 94/100 | PMID 38692949 ↗ |
| New Insights on Suicidal thinking and behavior during treatment with sertraline in late-life: What a 747-Participant Study Found Sertraline was associated with significantly lower HAMD Item 3 scores than placebo during treatment. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry • 2007-07-15 • Randomized Controlled Trial | N = 747 | 93/100 | PMID 17586782 ↗ |
| New Insights on Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients: What a 230-Participant Study Found This study confirmed rapid and robust reduction of depressive symptoms with esketamine nasal spray in severely ill patients with MDD who have active suicidal ideation with intent. The international journal of neuropsychopharmacology • 2021-01-20 • Phase III Randomized Trial | N = 230 | 88/100 | PMID 32861217 ↗ |
| Can This Approach Help? Inside the Latest Research on A phase 3, randomized, compared against a dummy pill (placebo), trial to evaluate Time since trauma exposure was a discriminator of CAPS-5 treatment response in the subgroup ≤ 9 years since the index event. Psychiatry research • 2024-04-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 38350291 ↗ |
| Can This Approach Help? Inside the Latest Research on Anxiety on suicidal ideation: exploratory analysis of a paroxetine versus Patients with high baseline anxiety showed a trend toward faster reduction of suicidal ideation with paroxetine compared with bupropion treatment (standard P=0.047; bootstrap P=0.077). International clinical psychopharmacology • 2018-09-15 • Randomized Controlled Trial | N = 36 | 88/100 | PMID 29864037 ↗ |
Suicide Patient Community & “People Like Me” Threads
Filter Suicide community threads and patient logs by age, biological sex, dosage, and treatment duration.